Group Health Cooperative will become the first health plan in Wisconsin to cover Cologuard, a noninvasive stool DNA colorectal cancer screening test.
Cologuard, developed by Exact Sciences, will be covered under laboratory benefits, covered by Group Health Cooperative of South Central Wisconsin. Primary care physicians will be able to prescribe the test.
"Making Cologuard available will hopefully encourage patients to get regular screenings and, in turn, improve survival results for this preventable cancer," said Group Health Cooperative CEO Kevin Hayden.
More articles on gastroenterology:
How to prepare for value-based care in GI
Drug therapy for celiac disease?
FDA grants tentative approval of UCERIS for ulcerative colitis
Cologuard, developed by Exact Sciences, will be covered under laboratory benefits, covered by Group Health Cooperative of South Central Wisconsin. Primary care physicians will be able to prescribe the test.
"Making Cologuard available will hopefully encourage patients to get regular screenings and, in turn, improve survival results for this preventable cancer," said Group Health Cooperative CEO Kevin Hayden.
More articles on gastroenterology:
How to prepare for value-based care in GI
Drug therapy for celiac disease?
FDA grants tentative approval of UCERIS for ulcerative colitis